BLEOMYCINE HIKMA 15 mg, powder for solution for injection bottle
Active ingredients: Bleomycin, Bleomycin sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for injectionbottleintramusculaire;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BLEOMYCINE HIKMA 15 mg, poudre pour solution injectable
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse;sous-cutanée
- Presentation description
- 1 flacon(s) en verre de 15 mg
- Marketing authorisation holder
- HIKMA FRANCE
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1970
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62789360CIP73013196CIP133400930131961Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SULFATE DE BLÉOMYCINEpoudre | — | SA |
| BLÉOMYCINEpoudre | 15 mg · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BLÉOMYCINE (SULFATE DE) équivalant à BLEOMYCINE 15 mg (correspondant à 15 000 UI) - BLEOMYCINE BELLON 15 mg, poudre pour solution injectable